What World Sight Day means to ophthalmologists and optometrists

Article

Coordinated by the International Agency for the Prevention of Blindness (IAPB), the international day of awareness is a reminder to "love your eyes."

14 October 2022 marks the 22nd World Sight Day (WSD), an annual day of awareness, held on the second Thursday of October, to focus global attention on blindness and vision impairment.

"This is a day where we focus the world's attention on the importance of eye care," Dr Constance Okeke, MSCE, of the Virginia Eye Consultants said.

Coordinated by the International Agency for the Prevention of Blindness (IAPB), the international day of awareness is a reminder to "love your eyes."

As part of its efforts, the IAPB and its members are working together to increase public awareness on vision issues and blindness, calling for a focus on vision issues and eye health.

As part of the WSD campaign, IAPB urges eye care professionals, including ophthalmologists and optometrists, to get involved.

"I think it's a great way to advocate and communicate for our patients and for what we do as optometrists; we make a big difference in our communities, and to patients' lives, and I think all optometrists should be celebrating World Sight Day," said Dr Maria Sampalis, owner of Sampalis Eye Care in Cranston/Providence, Rhode Island.

Today, IAPB is promoting a global challenge to unite the world, bringing people across the globe together to have their eyes tested. This year, IAPB is leading the call for people to prioritize their eye health and asking the world’s leaders to ensure eye care is accessible, available, and affordable to everyone everywhere.

"World Sight Day means a little bit different for me, not being from here originally," Dr Adam Ramsey, co-founder of Black EyeCare Perspective, said. "Understanding that the gift that we have—in this wonderful country that we're living in right now—where there is access to care so readily available."

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.